Skip to main content

Remix Therapeutics

Director, Clinical Pharmacology

Watertown, Massachusetts, United States

Location
Watertown, Massachusetts, United States
Work
Not stated
Employment
Not stated
Level
Director
Function
Healthcare
Pay
$206K – $252K a year (read from the ad)
Posted
11 days ago

Pay and the market here

The top of this role’s range, $252K a year, is 7% below the median of $270K for director healthcare jobs in Massachusetts (middle half $210K – $316K, 111 jobs that state pay).

18 healthcare jobs open in Watertown: 6% remote, 3 posted in the last 30 days.

Wondering how well you fit this one? OptiTalent Career checks each requirement against your own record, privately. About OptiTalent Career →

About the role

Remix Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin. Remix's REMaster™ technology platform leverages data science, biomolecular sciences and chemistry approaches to identify orally administered compounds that modulate gene expression. Remix's therapeutic approach led to the discovery of REM-422, an investigational small molecule designed to modulate RNA processing in oncology, currently being evaluated in two clinical programs, 1) the ARIA clinical study, a Phase 1/2 clinical study in adenoid cystic carcinoma (ACC), and 2) a Phase 1 clinical study in acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS).

Position Summary

The Director of Clinical Pharmacology will play a critical role in the design, execution, analysis, and interpretation of clinical pharmacology strategies across Remix Therapeutics' development programs. The initial focus of the role will be to lead the integrated clinical pharmacology strategy for REM-422, with primary responsibility for supporting late-stage development and potential regulatory submissions. The role will also provide clinical pharmacology leadership for emerging pipeline programs to support IND-enabling and early clinical development strategies.

The successful candidate will work in a highly cross-functional environment, partnering closely with Clinical Development, Regulatory Affairs, Clinical Operations, Biostatistics, DMPK, CMC and external collaborators to drive data-driven decision making and advance clinical development.

This is an opportunity to own the clinical pharmacology strategy for REM-422 as it advances toward a potential NDA, which would be Remix's first. You will shape dose selection, labeling, and regulatory strategy for an oral RNA-targeting therapy in ACC and AML/HR-MDS, and set the clinical pharmacology approach for the pipeline programs coming behind it.

Key Responsibilities

  • Lead the integrated clinical pharmacology strategy for REM-422, with primary responsibility for supporting late-stage development and potential regulatory submissions.
  • Drive dose optimization for REM-422 consistent with FDA Project Optimus expectations, including population PK, exposure–response, and model-informed drug development analyses.
  • Design and oversee clinical pharmacology studies evaluating food effect, drug–drug interactions, absorption and metabolism, and other intrinsic and extrinsic factors affecting REM-422 exposure.
  • Represent Clinical Pharmacology in regulatory interactions and lead relevant components of briefing documents and regulatory submissions.
  • Provide clinical pharmacology leadership for emerging pipeline programs, translating nonclinical pharmacology, ADME, PK, and toxicology data into integrated IND-enabling and early clinical development strategies.
  • Support human PK projections, first-in-human dose selection, dose-escalation design, PK/PD assessments, and early identification of clinical pharmacology risks.
  • Partner cross-functionally and oversee external vendors to ensure high-quality, timely delivery of studies, analyses, models, and regulatory documentation.

Qualifications

  • PhD, PharmD, or MD with relevant training in clinical pharmacology, pharmaceutical sciences, or a related discipline.
  • 10+ years of clinical pharmacology experience in the biotech or pharmaceutical industry, including oncology and clinical-stage development.
  • Demonstrated expertise in clinical pharmacology strategy and study design from early development through registration.
  • Direct experience contributing to an NDA/MAA submission, including authoring clinical pharmacology sections of the filing.
  • Deep understanding of PK/PD principles, modeling and simulation, and exposure–response analysis.
  • Proven cross-functional leadership and ability to integrate complex scientific data into strategic development decisions.
  • Excellent communication skills, with the ability to present to senior leadership and external stakeholders.

Salary Range

$206,000 - $252,000 USD

This range reflects the expected base salary for this position, plus bonus, equity, and benefits as applicable. Actual salaries may vary based on factors, such as skill, experience, and qualification for the role.

Source

Posted by Remix Therapeutics on their own hiring page, job-boards.greenhouse.io. OptiTalent shows it as published, read 07 Nov 2026 12:04 UTC; the original is the reference.

View the original ad ↗

More at Remix Therapeutics

  • Remix Therapeutics · Watertown, Massachusetts, United States

    Director$206K – $252K a yearOperations

    The Director will translate commercial strategy into an actionable enterprise launch plan, align stakeholders around priorities, and drive accountability for delivery. Working closely with Commercial, Medical Affairs, Clinical Development, Regulatory, Market Access, Technical…

  • Remix Therapeutics · Watertown, Massachusetts, United States

    Director$230K – $281K a year

    The GCP Quality Assurance candidate will manage activities related to the development, maintenance and oversight of GCP activities related to the Clinical Trial activities sponsored by company. The primary responsibilities will be to ensure both quality and compliance of…

  • Remix Therapeutics · Watertown, Massachusetts, United States

    Director$187K – $230K a yearData & AI

    Remix is seeking an Associate Director, Clinical Data Management to provide technical expertise and vendor oversight at a pivotal moment for REM-422 and the ACC patients we serve. Reporting to the SVP, Clinical Development Operations & Patient Advocacy and based at our…

  • Remix Therapeutics · Watertown, Massachusetts, United States

    Director$293K – $415K a yearHealthcare

    Remix is seeking a Head of Medical Affairs to provide medical affairs leadership for REM-422 and contribute to the development of future programs across the portfolio. REM-422 is an innovative investigational therapy targeting RNA splicing machinery, with adenoid cystic…